Yahoo!   My Yahoo!   Mail    Welcome, Guest [Sign In]Search Home   Help
Show: All Topics | from: last month | from: all sources | from: all locations | in: English
Results 1 - 30 of about 964 | Advanced Search | Preferences

Get Updates

Sort Results by: Relevance | Date
  • LONDON -- Novartis said it has licensed Debio 025, or alisporivir, a potential first-in-class antiviral agent currently in Phase IIb development for the treatment of hepatitis C. Debio 025 is the fir...
    MalaysiaNews.net - Feb 09 12:29 AM
  • Novartis Licenses Hepatitis C Drug
    Fox News - Feb 08 11:19 PM
  • Novartis buys rights to Hepatitis C drugNovartis buys rights to Hepatitis C drug
    The Economic Times - Feb 08 11:23 PM
  • ZURICH, Feb 9 (Reuters) - Swiss drugmaker Novartis bought exclusive rights Novartis to develop and market a drug, currently in mid-stage trials, for the treatment of hepatitis C, the group said on Tuesday. The antiviral agent Debio 025 has been in-licensed from Debiopharm Group, an independent company based in Switzerland, Novartis said. Novartis will make an upfront payment to Debiopharm and ...
    Interactive Investor - Feb 08 10:58 PM
  • Much of the treatment for hepatitis C is about healthy choices, and learning how to take care of yourself to protect your liver from further damage.
    KIVI Boise - Feb 08 8:43 AM
  • Pfizer has exercised its option to develop and commercialize Tacere Therapeutics' expressed RNAi-based hepatitis C treatment, Australia's Benitec announced last week.
    GenomeWeb News - Feb 09 8:45 AM
  • Former surgical scrub tech Kristen Diane Parker will let her guilty plea stand, even though she faces more than 20 years in prison for stealing hospital painkillers and infecting patients with hepatitis C.
    Denver Post - Feb 06 12:03 AM
  • A man who was infected with hepatitis C after receiving contaminated blood products joined hundreds of people to lobby MPs for a 'fair deal' for victims of the blunder.
    EDP24 - Eastern Daily Press - Feb 04 10:39 PM
  • DENVER (AP) - A drug-addicted surgery tech who admitted stealing painkillers and infecting patients with hepatitis C will face more prison time.
    KRDO Colorado Springs - Feb 05 4:51 PM
  • The liver processes your body's waste products and detoxifies harmful substances that you ingest, such as alcohol. It also processes many of the medications you take. The liver stores vitamins and minerals, cholesterol and other substances, then releases them into the blood as needed.
    KMIR 6 Palm Springs - Feb 08 8:39 AM
  • Former surgery scrub tech Kristen Parker will let her guilty plea stand even though she faces more than 20 years in prison for stealing painkillers and infecting patients with hepatitis C.
    Denver Post - Feb 05 8:32 AM
  • HALF of all hepatitis C cases in Scotland go undiagnosed each year, campaigners warned.
    The Scotsman - Feb 02 4:14 PM
  • When the Judds performed together for tens of thousands of fans at last summer’s CMA Music Festival in Nashville, Naomi Judd seemed emotionally overcome by the moment. It’s been more than 18 years since she retired from touring to battle potentially fatal hepatitis C, and the near-tears expression she displayed as she exchanged glances with people in the crowd suggested she misses the connection ...
    Great American Country - Feb 08 5:49 AM
  • The Marin AIDS Project, which has been helping county residents obtain HIV/AIDS and hepatitis C services since 1984, will celebrate its 25th anniversary Feb.
    Marin Independent Journal - Feb 08 12:16 AM
  • MASON CITY — The Cerro Gordo County Department of Public Health was awarded a $13,160 grant for HIV and hepatitis C prevention on Monday.
    The Globe Gazette - Feb 01 7:57 PM
  • For the Daily Journal The clients of the Mendocino County AIDS/Viral Hepatitis Network depend upon the organization for a variety of services.
    The Ukiah Daily Journal - Feb 09 8:44 AM
  • PRINCETON, N.J., Feb. 9 /PRNewswire-FirstCall/ -- Pharmasset, Inc.
    redOrbit - Feb 09 4:08 PM
  • LAUSANNE, Switzerland, February 9 /PRNewswire/ -- Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today announced the signature of an exclusive licence agreement with Novartis for the development, manufacture and commercialisation of Debio 025 (alisporivir), a selective ...
    redOrbit - Feb 09 3:08 AM
  • Thank you for publishing letters (2 February) from those affected by the contaminated blood disaster supporting the stance taken by Ruth Rendell . In another letter, the writer takes issue with Rendell for fanning the flames of stigma for those who have HIV . We sympathise with the correspondent's position and in fact we have battled over many years to reduce the stigma of HIV and hepatitis C ...
    Guardian Unlimited - Feb 07 8:51 PM
  • Lausanne (ots) - Debiopharm Group[TM] (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription ...
    FinanzNachrichten - Feb 08 11:00 PM
  • Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today announced the signature of an exclusive licence agreement with Novartis for the development, manufacture and commercialisation of Debio 025 (alisporivir), a selective, first-in-class cyclophilin (Cyp) inhibitor with a potent anti ...
    News-Medical-Net - Feb 09 1:46 AM
  • REGENERX BIOPHARMACEUTICALS, INC. announced today that researchers have correlated Tβ4 levels with the clinical course of patients with hepatitis B virus-related liver failure. It was reported that serum thymosin β4 levels were significantly lower in patients with chronic hepatitis B infection and that the magnitude of the reduction of thymosin β4 was closely related to the severity of the ...
    News-Medical-Net - Feb 09 3:31 AM
  • Chronic hepatitis B virus (HBV) infection is the most important risk factor of liver cirrhosis in HBV endemic areas. A research group in China performed a large epidemiological study to investigate the association of HBV genotypes with the development of probable cirrhosis in community-based population. They found that HBV genotype C was independently associated with probable cirrhosis in the ...
    EurekAlert! - Feb 09 2:36 PM
  • CHICAGO, Feb. 9 /PRNewswire/ -- STDUniversity.org is the first website to provide an interactive, personalized STD test recommendation developed by academic and medical experts.
    redOrbit - Feb 09 1:08 PM
  • A drug-addicted surgery tech who admitted stealing painkillers and infecting patients with Hepatitis C will face more prison time. Kristen Diana Parker renewed her guilty plea Friday before a federal judge in Denver. Parker had already pleaded guilty in an agreement with prosecutors that was have sent her to prison for 20 years. But U.S. district Judge Robert Blackburn rejected that plea, saying ...
    KOAA Colorado Springs - Pueblo - Feb 06 6:35 AM
  • LEIDEN, NETHERLANDS--(Marketwire - February 9, 2010) -
    Marketwire - Feb 08 11:28 PM
  • Qiagen N.V. / QIAGEN Reports Strong Fourth Quarter and Fiscal 2009 Results processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.
    4investors - Feb 08 1:54 PM
  • VANCOUVER, British Columbia (AP) — Five blocks away from the venue for Vancouver’s Winter Olympics opening ceremony, four grizzled addicts huddle in the rain, injecting themselves with heroin behind a trash bin.
    Park Hills Daily Journal - Feb 09 11:57 AM
  • DATED MEETINGSPeripheral Neuropathy/ RLS Support Group: Unity Church of Martin County, 211 S.E. Central Parkway, Stuart, 2-4 p.m. Feb. 11. Dr. Hal Tobias, neurologist, will be present for questions. (772) 283-5137.Better Breathers Club: Sponsored by the American Lung Association. Group for people with COPD/lung disease, caregivers. Martin Memorial Hospital North/Cancer Center Bldg, 501 East ...
    St. Lucie News Tribune - Feb 09 5:59 AM
  • SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) and its partner Sigma-Tau S.p.A., announced additional topline results in a clinical study evaluating the potential of ZADAXIN® (thymalfasin) to enhance immune response to the MF59 adjuvanted H1N1 influenza monovalent vaccine, Focetria™ from Novartis. According to investigators, ZADAXIN treatment given with the H1N1 vaccine led to a statistically ...
    Medical News Today - Feb 08 8:33 AM
1

YAHOO! NEWS by category


Show: | All Topics | from: last month | from: all sources | from: all locations | in: English

Copyright © 2010 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Submit Your Site - Help